Clinical Trial Update: Umbilical Cord Blood Transplant for Hematological Malignancies [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating umbilical cord blood transplantation for hematologic malignancies has completed enrollment and reporting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Acute Myeloid Leukemia
• Chronic Myeloid Leukemia
• Hodgkin Lymphoma
• Multiple Myeloma
• Myelodysplastic Syndromes
• Non-hodgkin Lymphoma

Snippet

Sponsor: University of Pennsylvania | Conditions: CML, AML | Phase 1 | Status: COMPLETED